AAM
GSK icon

Auxier Asset Management’s GSK GSK Stock Holding History

Auxier Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Hold
27,532
– – 0.22% 94
2025
Q4 		$1.35M Sell
27,532
-679
-2% -$31.7K 0.19% 99
2025
Q3 		$1.22M Sell
28,211
-331
-1% -$12.9K 0.17% 103
2025
Q2 		$1.1M Sell
28,542
-305
-1% -$11.7K 0.16% 103
2025
Q1 		$1.12M Sell
28,847
-515
-2% -$18.9K 0.17% 100
2024
Q4 		$993K Sell
29,362
-1,830
-6% -$65.9K 0.15% 104
2024
Q3 		$1.28M Sell
31,192
-360
-1% -$14.7K 0.19% 93
2024
Q2 		$1.21M Sell
31,552
-160
-0.5% -$6.73K 0.19% 92
2024
Q1 		$1.36M Sell
31,712
-1,880
-6% -$77.5K 0.21% 95
2023
Q4 		$1.24M Sell
33,592
-1,704
-5% -$61.2K 0.2% 98
2023
Q3 		$1.28M Sell
35,296
-180
-0.5% -$6.39K 0.22% 91
2023
Q2 		$1.26M Buy
35,476
+705
+2% +$25.3K 0.21% 95
2023
Q1 		$1.24M Sell
34,771
-332
-0.9% -$11.6K 0.21% 94
2022
Q4 		$1.23M Sell
35,103
-358
-1% -$11.9K 0.21% 94
2022
Q3 		$1.04M Sell
35,461
-1,276
-3% -$48.4K 0.2% 96
2022
Q2 		$2M Sell
36,737
-16
-0% -$883 0.36% 77
2022
Q1 		$2M Sell
36,753
-4,688
-11% -$255K 0.32% 78
2021
Q4 		$2.28M Sell
41,441
-108
-0.3% -$5.62K 0.35% 75
2021
Q3 		$1.98M Sell
41,549
-320
-0.8% -$16.1K 0.34% 77
2021
Q2 		$2.08M Sell
41,869
-1,656
-4% -$79.6K 0.35% 78
2021
Q1 		$1.94M Sell
43,525
-1,360
-3% -$61.7K 0.33% 80
2020
Q4 		$2.06M Sell
44,885
-112
-0.2% -$5.14K 0.38% 72
2020
Q3 		$2.12M Sell
44,997
-240
-0.5% -$12K 0.44% 66
2020
Q2 		$2.31M Buy
45,237
+156
+0.3% +$8K 0.51% 61
2020
Q1 		$2.13M Sell
45,081
-480
-1% -$25.6K 0.53% 57
2019
Q4 		$2.68M Sell
45,561
-260
-0.6% -$14.5K 0.5% 62
2019
Q3 		$2.44M Sell
45,821
-1,872
-4% -$96.3K 0.49% 61
2019
Q2 		$2.39M Sell
47,693
-1,893
-4% -$95K 0.48% 63
2019
Q1 		$2.59M Buy
49,586
+320
+0.6% +$16K 0.53% 59
2018
Q4 		$2.35M Sell
49,266
-472
-0.9% -$23.2K 0.52% 59
2018
Q3 		$2.5M Sell
49,738
-480
-1% -$24.4K 0.47% 63
2018
Q2 		$2.53M Sell
50,218
-16,640
-25% -$838K 0.51% 60
2018
Q1 		$3.27M Sell
66,858
-1,960
-3% -$91.3K 0.65% 50
2017
Q4 		$3.05M Sell
68,818
-280
-0.4% -$12.9K 0.59% 56
2017
Q3 		$3.51M Sell
69,098
-429
-0.6% -$21.8K 0.71% 47
2017
Q2 		$3.75M Sell
69,527
-991
-1% -$52.8K 0.77% 47
2017
Q1 		$3.72M Sell
70,518
-880
-1% -$44.6K 0.78% 46
2016
Q4 		$3.44M Sell
71,398
-13,220
-16% -$653K 0.75% 49
2016
Q3 		$4.56M Sell
84,618
-3,968
-4% -$218K 1.02% 37
2016
Q2 		$4.8M Sell
88,586
-440
-0.5% -$23.2K 1.1% 32
2016
Q1 		$4.51M Sell
89,026
-19,800
-18% -$986K 1.07% 35
2015
Q4 		$5.49M Sell
108,826
-9,980
-8% -$509K 1.24% 28
2015
Q3 		$5.71M Buy
118,806
+1,620
+1% +$84.3K 1.33% 28
2015
Q2 		$6.1M Buy
117,186
+9,060
+8% +$510K 1.27% 29
2015
Q1 		$6.24M Sell
108,126
-2,828
-3% -$162K 1.26% 28
2014
Q4 		$5.93M Buy
110,954
+4,140
+4% +$232K 1.18% 33
2014
Q3 		$6.14M Buy
106,814
+19,918
+23% +$1.22M 1.28% 27
2014
Q2 		$5.81M Sell
86,896
-440
-0.5% -$29.8K 1.19% 28
2014
Q1 		$5.83M Sell
87,336
-2,400
-3% -$162K 1.24% 30
2013
Q4 		$5.99M Sell
89,736
-440
-0.5% -$28.5K 1.26% 30
2013
Q3 		$5.66M Sell
90,176
-120
-0.1% -$7.72K 1.31% 26
2013
Q2 		$5.64M Buy
+90,296
New +$5.73M 1.36% 25

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Auxier Asset Management's GSK Position: Q1 2026 in Review

Auxier Asset Management held its GSK (GSK) position steady in Q1 2026 at 27,532 shares worth $1.52M. The position accounts for 0.22% of the portfolio, ranked #94.

Auxier Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.24M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Auxier Asset Management held 27,532 shares of GSK worth $1.52M as of Q1 2026.
  • Auxier Asset Management left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.22% of Auxier Asset Management's portfolio in Q1 2026, its #94 holding.
  • Auxier Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Auxier Asset Management's GSK position peaked at $6.24M in Q1 2015.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.